456 - Predictors of the Placebo Response in Irritable Bowel Syndrome
Sarah Ballou(Beth Israel Deaconess Medical Center), Anthony Lembo(Cleveland Clinic), William Hirsch(Beth Israel Deaconess Medical Center), Ted J. Kaptchuk(Beth Israel Deaconess Medical Center), Thomas Sommers(Hadassah Medical Center), Vikram Rangan(Beth Israel Deaconess Medical Center), Judy Nee(Beth Israel Deaconess Medical Center), Prashant Singh(Michigan Medicine), Alissa Beath(Macquarie University)
Cited by 0
Related Papers
Bowel Disorders
|Gastroenterology|2016|2.8k
Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis
|Clinical Gastroenterology and Hepatology|2018|1.7k
Biological, clinical, and ethical advances of placebo effects
|The Lancet|2010|1.3k
Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
|BMJ|2008|1.2k
Acupuncture: Theory, Efficacy, and Practice
|Annals of Internal Medicine|2002|974